Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-28
2000-01-25
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514356, 514337, 514444, 514247, 514871, 514859, 536 243, 435 6, A01N 4340, A01N 4306, A01N 4358
Patent
active
060179384
ABSTRACT:
The present invention relates to a method of treating acne using short-term contact with an acetylenic retinoid, preferably tazarotene and related compounds.
REFERENCES:
patent: 5089509 (1992-02-01), Chandraratna
Leyden, James J., Emerging Topical Retinoid Therapies, Journal of the American Academy of Dermatology, Apr. 1998, vol. 38, No. 4, pp. S1-S4.
Chandraratna, R., Tazarotene--first of a new generation of receptor-selective retinoids, British Journal of Dermatology 1996, vol. 135, pp. 18-25.
Topical Retinoid Therapy, National Psoriasis Foundation, 1997, pp. 1-6.
Kim Vickie
MacMillan Keith D.
LandOfFree
Short contact treatment for acne does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Short contact treatment for acne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Short contact treatment for acne will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316181